LINDA MELERINE: Open Payments
NPI 1992925242 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,976 in 104 payments from 24 companies in 2025. Trend: 2023 $2,022 · 2024 $1,677 · 2025 $1,976
Food & beverage: $1,976
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $387 |
| GlaxoSmithKline, LLC. | 21 | $338 |
| PFIZER INC. | 16 | $205 |
| ABBVIE INC. | 12 | $187 |
| Novo Nordisk Inc | 11 | $171 |
| Lilly USA, LLC | 8 | $120 |
| Exact Sciences Corporation | 6 | $111 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Dexcom, Inc. | 2 | $43 |
| Saluda Medical Americas, Inc. | 1 | $42 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, BREZTRI, SHINGRIX, ELIQUIS, CREON, MOUNJARO, JARDIANCE.
Industry payments across LA — which companies pay providers there.
